Search PLUR
Pluri Inc.
NasdaqCM · CIK 1158780
Last close1.01
Daily change-0.02 (-1.94%)
10 Years gain-99.20%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
PLUR · STANDARD
SIC 2836 · Biological Products, (No Diagnostic Substances) · Fiscal year end 0630
Fundamental
55.6Momentum
0.0Acceleration
0.0Confidence
79.0Annual Revenue13
Quarterly Revenue40
Annual CFO16
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth17.6 / 25
Quality12.5 / 25
Capital Efficiency11.2 / 20
Balance Sheet8.5 / 15
Shareholder Economics3.0 / 10
Forward Indicators0.0 / 5
Signals
No positive signals calculated.
Warnings
Negative FCF · HIGHLatest free cash flow is negative.
Gross margin compression · MEDIUMGross margin compressed by 9.1249 percentage points.
Operating margin compression · MEDIUMOperating margin compressed by 322.9323 percentage points.
Heavy share dilution · HIGHDiluted share count increased 53.1914%.
High SBC · MEDIUMStock based compensation is high relative to revenue or FCF.
Key Metrics
Revenue Growth TTM4.35%OK
Revenue CAGR 3Y52.41%OK
Gross Margin43%OK
Operating Margin-2,410.84%OK
FCF Margin-2,010.1%OK
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Y771.9%OK
Net Debt / CFO0.17xOK
Diluted Share Growth 1Y53.19%OK
SBC / Revenue378.87%OK
SBC / FCF-18.85%OK
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 FY Jun 30, 2026 | $1.02M | $453,000.00 | -$24.94M | -$19.59M | -$20.22M | 44.59% | -2,454.53% | -1,990.26% | n/a | 9.74M |
| 2026 FY Jun 30, 2025 | $1.34M | $654,000.00 | -$22.18M | -$18.21M | -$19.83M | 48.95% | -1,659.88% | -1,484.21% | n/a | 6.34M |
| 2025 FY Jun 30, 2024 | $326,000.00 | $322,000.00 | -$22.16M | -$18.02M | -$18.34M | 98.77% | -6,796.93% | -5,626.99% | -2,676.58% | 5.24M |
| 2024 FY Jun 30, 2023 | $287,000.00 | $278,000.00 | -$27.25M | -$22.86M | -$23.12M | 96.86% | -9,493.38% | -8,055.4% | -152.32% | 4.58M |
| 2023 FY Jun 30, 2022 | $234,000.00 | $234,000.00 | -$41.59M | -$36.50M | -$36.78M | 100% | -17,774.79% | -15,718.38% | -527.08% | 32.19M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $1.08M | sum latest 4 fiscal quarters Revenue | OK | 0001213900-26-098862, 0001213900-25-109174 |
| Revenue Growth TTM | 4.35% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001213900-26-098862, 0001213900-25-109174 |
| Revenue CAGR 3Y | 52.41% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001213900-26-098862 |
| Revenue CAGR 5Y | 113.32% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001213900-26-098862 |
| Gross Profit CAGR 3Y | 17.68% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001213900-26-098862 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001213900-26-098862, 0001213900-25-109174 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | 0001213900-26-098862, 0001213900-25-109174 |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 43% | Gross Profit / Revenue | OK | 0001213900-26-098862, 0001213900-25-109174 |
| Operating Margin | -2,410.84% | Operating Income / Revenue | OK | 0001213900-26-098862, 0001213900-25-109174 |
| FCF Margin | -2,010.1% | (CFO - CapEx) / Revenue | OK | 0001213900-26-098862, 0001213900-25-109174 |
| Net Debt / CFO | 0.17x | Net Debt / CFO | OK | 0001213900-26-056586, 0001213900-26-098862 |
| Current Ratio | 0.33x | Current Assets / Current Liabilities | OK | derived |
| SBC / Revenue | 378.87% | SBC / Revenue | OK | 0001213900-26-098862, 0001213900-25-109174 |
| Revenue per Diluted Share | $0.11 | Revenue / Diluted Shares | OK | 0001213900-26-098862, 0001213900-25-109174 |